VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 295 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $285,000 | +17.8% | 12,301 | -18.5% | 0.01% | +22.2% |
| Q1 2018 | $242,000 | +3.4% | 15,101 | +33.6% | 0.01% | 0.0% |
| Q4 2017 | $234,000 | +39.3% | 11,301 | -3.1% | 0.01% | +28.6% |
| Q3 2017 | $168,000 | -41.5% | 11,665 | -29.2% | 0.01% | -46.2% |
| Q2 2017 | $287,000 | +126.0% | 16,465 | +52.4% | 0.01% | +85.7% |
| Q1 2017 | $127,000 | -49.4% | 10,807 | +5.8% | 0.01% | -46.2% |
| Q3 2016 | $251,000 | -11.6% | 10,212 | +268.1% | 0.01% | -13.3% |
| Q4 2015 | $284,000 | -28.5% | 2,774 | +23.9% | 0.02% | -31.8% |
| Q3 2015 | $397,000 | -32.7% | 2,239 | -15.7% | 0.02% | -15.4% |
| Q2 2015 | $590,000 | +159.9% | 2,656 | +134.2% | 0.03% | +73.3% |
| Q1 2015 | $227,000 | – | 1,134 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |